BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15363637)

  • 1. Carnitine acyltransferases and their influence on CoA pools in health and disease.
    Ramsay RR; Zammit VA
    Mol Aspects Med; 2004; 25(5-6):475-93. PubMed ID: 15363637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The carnitine acyltransferases and their role in modulating acyl-CoA pools.
    Ramsay RR; Arduini A
    Arch Biochem Biophys; 1993 May; 302(2):307-14. PubMed ID: 8489235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of carnitine in intracellular metabolism.
    Bremer J
    J Clin Chem Clin Biochem; 1990 May; 28(5):297-301. PubMed ID: 2199593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine, mitochondrial function and therapy.
    Zammit VA; Ramsay RR; Bonomini M; Arduini A
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1353-62. PubMed ID: 19716391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells.
    Peluso G; Petillo O; Margarucci S; Grippo P; Melone MA; Tuccillo F; Calvani M
    J Cell Physiol; 2005 May; 203(2):439-46. PubMed ID: 15515015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid beta-oxidation in peroxisomes and mitochondria: the first, unequivocal evidence for the involvement of carnitine in shuttling propionyl-CoA from peroxisomes to mitochondria.
    Jakobs BS; Wanders RJ
    Biochem Biophys Res Commun; 1995 Aug; 213(3):1035-41. PubMed ID: 7654220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of L-carnitine on mitochondrial acyl CoA esters in the ischemic dog heart.
    Kobayashi A; Fujisawa S
    J Mol Cell Cardiol; 1994 Apr; 26(4):499-508. PubMed ID: 8072006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
    Folmes CD; Lopaschuk GD
    Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible functions of short-chain and medium-chain carnitine acyltransferases.
    Bieber LL; Emaus R; Valkner K; Farrell S
    Fed Proc; 1982 Oct; 41(12):2858-62. PubMed ID: 7128832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [L-carnitine: metabolism, functions and value in pathology].
    Jacob C; Belleville F
    Pathol Biol (Paris); 1992 Nov; 40(9):910-9. PubMed ID: 1296165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical derangements in ischemic myocardium: the role of carnitine.
    Siliprandi N; Di Lisa F; Toninello A
    G Ital Cardiol; 1984 Oct; 14(10):804-8. PubMed ID: 6240423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and expression of human carnitine octanoyltransferase: evidence for its role in the peroxisomal beta-oxidation of branched-chain fatty acids.
    Ferdinandusse S; Mulders J; IJlst L; Denis S; Dacremont G; Waterham HR; Wanders RJ
    Biochem Biophys Res Commun; 1999 Sep; 263(1):213-8. PubMed ID: 10486279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of carnitine esters in brain neuropathology.
    Virmani A; Binienda Z
    Mol Aspects Med; 2004; 25(5-6):533-49. PubMed ID: 15363640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.
    Rubio-Gozalbo ME; Bakker JA; Waterham HR; Wanders RJ
    Mol Aspects Med; 2004; 25(5-6):521-32. PubMed ID: 15363639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolism of long chain fatty acids in the normal and pathologic heart: effects of ischemia].
    Feuvray D; Leblond Y
    Diabete Metab; 1984 Dec; 10(5):316-23. PubMed ID: 6397367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
    Ussher JR; Lopaschuk GD
    Cardiovasc Res; 2008 Jul; 79(2):259-68. PubMed ID: 18499682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Status of carnitine in clinical nutrition. An explanatory trial].
    Böhles H
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 3():33-6. PubMed ID: 3119487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.